title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board - Climb Bio  ( NASDAQ:CLYM ) ",20241111T120000,https://www.benzinga.com/pressreleases/24/11/g41875065/climb-bio-appoints-douglas-e-williams-ph-d-as-chair-of-the-board,PFE,0.055881,Neutral,-0.043982
"Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board",20241111T120000,https://www.globenewswire.com/news-release/2024/11/11/2978194/0/en/Climb-Bio-Appoints-Douglas-E-Williams-Ph-D-as-Chair-of-the-Board.html,PFE,0.033468,Neutral,-0.042717
Pfizer's  ( PFE )  Ulcerative Colitis Pill Velsipity Gets EU Nod,20240220T120900,https://www.zacks.com/stock/news/2228287/pfizers-pfe-ulcerative-colitis-pill-velsipity-gets-eu-nod,PFE,0.354741,Somewhat-Bullish,0.245922
Report Forecasts Promising Future for Alzheimer's Disease Market with New Therapeutic Approaches | Brandessence Market Research,20230515T093200,https://www.prnewswire.com/news-releases/report-forecasts-promising-future-for-alzheimers-disease-market-with-new-therapeutic-approaches--brandessence-market-research-301824407.html,PFE,0.017394,Neutral,0.112745
"The Zacks Analyst Blog Highlights Lilly, Merck, Roche, Pfizer and Moderna",20220620T092400,https://www.zacks.com/stock/news/1940866/the-zacks-analyst-blog-highlights-lilly-merck-roche-pfizer-and-moderna,PFE,0.334425,Neutral,-0.080136
"Pharma Stock Roundup: FDA Panel Nod for PFE, MRNA Young Kids' COVID Jabs & More",20220617T123700,https://www.zacks.com/stock/news/1940269/pharma-stock-roundup-fda-panel-nod-for-pfe-mrna-young-kids-covid-jabs-more,PFE,0.443239,Neutral,-0.118991
"The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK",20220616T140943,https://www.benzinga.com/general/biotech/22/06/27737919/the-daily-biotech-pulse-roches-alzheimers-drug-fails-advisors-back-pfizer-moderna-shots-for-young,PFE,0.098719,Neutral,-0.002903
"The Daily Biotech Pulse: Moderna Files For 2nd COVID Booster Shot Authorization, Lexicon Secures Debt Funding, Amneal Gets Sub-License to Manufacture Generic COVID Pill",20220318T115038,https://www.benzinga.com/general/biotech/22/03/26197749/the-daily-biotech-pulse-moderna-files-for-2nd-covid-booster-shot-authorization-lexicon-secures-de,PFE,0.135576,Neutral,0.003182
"The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug",20220708T121902,https://www.benzinga.com/general/biotech/22/07/27998206/the-daily-biotech-pulse-pfizer-inks-pact-with-africa-for-covid-19-pills-emergent-bio-ridgeback-to,PFE,0.126985,Neutral,0.010481
103 Biggest Movers From Yesterday,20220511T102237,https://www.benzinga.com/news/22/05/27130447/103-biggest-movers-from-yesterday,PFE,0.042685,Neutral,0.003708
DNA Tech Co. Launches MRNA Platform and Files Two Patents,20230830T155527,https://www.investorideas.com/news/2023/biotech/08302Applied-DNA-Sciences.asp,PFE,0.031446,Neutral,0.144016
Applied DNA Sciences  ( NASDAQ:APDN )  Coverage Initiated by Analysts at StockNews.com,20230708T050842,https://www.defenseworld.net/2023/07/08/applied-dna-sciences-nasdaqapdn-coverage-initiated-by-analysts-at-stocknews-com.html,PFE,0.085936,Neutral,0.086494
"The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight",20231122T220100,https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-b-cell-lymphomas-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-mantle-cell-lymphoma-marginal-zone-lymphoma-waldenstrom-macroglobulinemia-and-burkitt-lymphoma--301995626.html,PFE,0.013173,Neutral,0.026023
3 Monkeypox Stocks That Soared Last Week,20220523T091300,https://www.fool.com/investing/2022/05/23/3-monkeypox-stocks-that-soared-last-week/,PFE,0.05333,Somewhat-Bullish,0.24866
"The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More",20220516T133825,https://www.benzinga.com/general/biotech/22/05/27217168/the-week-ahead-in-biotech-may-16-21-gene-cell-therapy-conference-presentations-tapering-earnings-,PFE,0.122362,Neutral,0.006818
"The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More",20220414T133544,https://www.benzinga.com/general/biotech/22/04/26630399/the-daily-biotech-pulse-pfizer-biontech-covid-19-booster-data-in-kids-regenerons-covid-19-therapy,PFE,0.125635,Neutral,0.01172
"Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA",20240313T120000,https://www.globenewswire.com/news-release/2024/03/13/2845349/0/en/Pyxis-Oncology-Expands-Board-of-Directors-with-Appointment-of-Santhosh-Palani-Ph-D-CFA.html,PFE,0.0428,Neutral,0.019547
"Dianthus Therapeutics Enhances Leadership Team with Appointment of Jeffrey Stavenhagen, Ph.D., as Chief Scientific Officer - Dianthus Therapeutics  ( NASDAQ:DNTH ) ",20231129T210500,https://www.benzinga.com/pressreleases/23/11/g36011541/dianthus-therapeutics-enhances-leadership-team-with-appointment-of-jeffrey-stavenhagen-ph-d-as-chi,PFE,0.032691,Neutral,-0.053857
Pyxis Oncology M&A Spotlight Signals Potential Growth Amidst Competitive ADC Landscape: Analyst - Pyxis Oncology  ( NASDAQ:PYXS ) ,20230905T164314,https://www.benzinga.com/general/biotech/23/09/34244004/pyxis-oncology-m-a-spotlight-signals-potential-growth-amidst-competitive-adc-landscape-analyst,PFE,0.405651,Bullish,0.524373
Pyxis Oncology Successfully Completes Acquisition of Apexigen - Pyxis Oncology  ( NASDAQ:PYXS ) ,20230823T123500,https://www.benzinga.com/pressreleases/23/08/g34002489/pyxis-oncology-successfully-completes-acquisition-of-apexigen,PFE,0.029472,Somewhat-Bullish,0.198825
Pyxis Oncology Successfully Completes Acquisition of Apexigen,20230823T123500,https://www.globenewswire.com/news-release/2023/08/23/2730427/0/en/Pyxis-Oncology-Successfully-Completes-Acquisition-of-Apexigen.html,PFE,0.030524,Somewhat-Bullish,0.186808
CancerVAX CEO Ryan Davies Discusses Biotech Entrepreneurship with Pyxis Oncology CEO Dr. Lara Sullivan,20230710T070100,https://www.benzinga.com/pressreleases/23/07/g33159728/cancervax-ceo-ryan-davies-discusses-biotech-entrepreneurship-with-pyxis-oncology-ceo-dr-lara-sulli,PFE,0.328819,Neutral,0.118708
Pyxis  ( PYXS )  Up on Advancing Cancer Therapy Candidates,20230531T133900,https://www.zacks.com/stock/news/2101934/pyxis-pyxs-up-on-advancing-cancer-therapy-candidates,PFE,0.258351,Somewhat-Bullish,0.204503
"Apexigen  ( APGN )  to Get Acquired by Pyxis Oncology, Stock Up",20230525T192500,https://www.zacks.com/stock/news/2099939/apexigen-apgn-to-get-acquired-by-pyxis-oncology-stock-up,PFE,0.084127,Neutral,0.03958
Small SPAC Biotech Apexigen To Be Acquired Pyxis Oncology For $16M - Pyxis Oncology  ( NASDAQ:PYXS ) ,20230524T182848,https://www.benzinga.com/general/biotech/23/05/32554799/small-spac-biotech-apexigen-to-be-acquired-pyxis-oncology-for-16m,PFE,0.371523,Somewhat-Bullish,0.254431
"Pyxis Oncology to Acquire Apexigen - Pyxis Oncology  ( NASDAQ:PYXS ) , Apexigen  ( NASDAQ:APGN ) ",20230524T104500,https://www.benzinga.com/pressreleases/23/05/g32547139/pyxis-oncology-to-acquire-apexigen,PFE,0.0367,Neutral,0.140027
Pyxis Oncology to Acquire Apexigen,20230524T104500,https://www.globenewswire.com/news-release/2023/05/24/2675054/0/en/Pyxis-Oncology-to-Acquire-Apexigen.html,PFE,0.030216,Neutral,0.127603
"3 Top Penny Stocks To Watch As GSIT, OMH Stock Explode",20230515T170303,https://pennystocks.com/featured/2023/05/15/3-top-penny-stocks-to-watch-gsit-omh-stock-explode/,PFE,0.116536,Neutral,0.066961
"$5M Bet On Pyxis Oncology? Check Out These 4 Penny Stocks Insiders Are Buying - Bird Glb  ( NYSE:BRDS ) , Champions Oncology  ( NASDAQ:CSBR ) ",20230322T112113,https://www.benzinga.com/trading-ideas/long-ideas/23/03/31453546/5m-bet-on-pyxis-oncology-check-out-these-4-penny-stocks-insiders-are-buying,PFE,0.096283,Neutral,0.13807
"Pyxis Oncology Announces Dosing of First Subject in Phase 1 Trial of PYX-201, a Novel ADC for Solid Tumors",20230316T113000,https://www.globenewswire.com/news-release/2023/03/16/2628535/0/en/Pyxis-Oncology-Announces-Dosing-of-First-Subject-in-Phase-1-Trial-of-PYX-201-a-Novel-ADC-for-Solid-Tumors.html,PFE,0.06515,Somewhat-Bullish,0.160302
Pyxis Oncology Announces FDA Clearance of Two IND Applications,20221201T114500,https://www.globenewswire.com/news-release/2022/12/01/2565733/0/en/Pyxis-Oncology-Announces-FDA-Clearance-of-Two-IND-Applications.html,PFE,0.031654,Neutral,0.092079
Pyxis Oncology Announces Leadership Changes,20220413T103500,https://www.globenewswire.com/news-release/2022/04/13/2421745/0/en/Pyxis-Oncology-Announces-Leadership-Changes.html,PFE,0.03368,Bullish,0.855864
"Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In - Corbus Pharmaceuticals  ( NASDAQ:CRBP ) , AbbVie  ( NYSE:ABBV ) ",20240514T173240,https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38803783/will-pharma-and-healthcare-have-competitive-edge-in-cannabis-post-rescheduling-data,PFE,0.088964,Neutral,0.0
"Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight",20240409T214100,https://www.prnewswire.com/news-releases/global-tissue-banking-market-to-exhibit-growth-at-a-considerable-cagr-of-6-by-2030-assesses-delveinsight-302110459.html,PFE,0.022991,Neutral,0.033133
"Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight",20240124T220100,https://www.prnewswire.com/news-releases/drug-eluting-balloons-global-market-is-expected-to-expand-at-a-healthy-growth-rate-of-8-by-2028-predicts-delveinsight-302042856.html,PFE,0.025985,Neutral,0.033663
"Heart Failure Treatment Drug Market to Accelerate Immensely by 2032, Predicts DelveInsight",20240115T220500,https://www.prnewswire.com/news-releases/heart-failure-treatment-drug-market-to-accelerate-immensely-by-2032-predicts-delveinsight-302034593.html,PFE,0.023441,Neutral,0.03228
Cardiol Therapeutics Fights Heart Inflammation With Novel Formulations - Cardiol Therapeutics  ( NASDAQ:CRDL ) ,20231012T135319,https://www.benzinga.com/general/biotech/23/10/35220787/cardiol-therapeutics-fights-heart-inflammation-with-novel-formulations,PFE,0.033328,Neutral,-0.056748
QURE Soars on FDA Alignment for Speedy Approval of Huntington's Drug,20241211T150200,https://www.zacks.com/stock/news/2382224/qure-soars-on-fda-alignment-for-speedy-approval-of-huntingtons-drug,PFE,0.127682,Neutral,0.086009
"Gene Therapy Market Set for 19% CAGR Surge, Reaching USD 38.34 Billion by 2031 | SkyQuest Technology",20240912T133000,https://www.benzinga.com/pressreleases/24/09/g40833623/gene-therapy-market-set-for-19-cagr-surge-reaching-usd-38-34-billion-by-2031-skyquest-technology,PFE,0.039878,Neutral,0.026899
uniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress,20230801T110500,https://www.globenewswire.com/news-release/2023/08/01/2715661/0/en/uniQure-Announces-Second-Quarter-2023-Financial-Results-and-Highlights-Recent-Company-Progress.html,PFE,0.016304,Neutral,0.049953
uniQure  ( NASDAQ:QURE )  Stock Rating Lowered by StockNews.com,20230709T054241,https://www.defenseworld.net/2023/07/09/uniqure-nasdaqqure-stock-rating-lowered-by-stocknews-com.html,PFE,0.049526,Neutral,0.031989
uniQure  ( NASDAQ:QURE )  Downgraded to Sell at StockNews.com,20230708T081641,https://www.defenseworld.net/2023/07/08/uniqure-nasdaqqure-downgraded-to-sell-at-stocknews-com.html,PFE,0.044801,Neutral,0.031872
uniQure Announces Leadership Addition to Support Advancement of Clinical Programs,20230626T111100,https://www.globenewswire.com/news-release/2023/06/26/2694317/0/en/uniQure-Announces-Leadership-Addition-to-Support-Advancement-of-Clinical-Programs.html,PFE,0.036532,Neutral,0.025962
uniQure Announces First Quarter 2022 Financial Results and Highlights Recent Company Progress,20220502T110500,https://www.globenewswire.com/news-release/2022/05/02/2433340/0/en/uniQure-Announces-First-Quarter-2022-Financial-Results-and-Highlights-Recent-Company-Progress.html,PFE,0.016796,Somewhat-Bullish,0.210379
"Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate - Aquestive Therapeutics  ( NASDAQ:AQST ) ",20240930T182549,https://www.benzinga.com/analyst-ratings/analyst-color/24/09/41101457/optimism-around-aquestive-as-it-moves-forward-with-severe-allergy-baldness-candidat,PFE,0.176502,Neutral,0.008883
Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive ... - PR Newswire,20231201T183000,https://www.prnewswire.com/news-releases/neuromuscular-disease-therapeutics-market-size-to-grow-by-usd-65-13-billion-from-2022-2027-aquestive-therapeutics-inc-bausch-health-companies-inc-biogen-inc-and-more-among-the-major-companies-in-the-market--technavio-302002042.html,PFE,0.059636,Neutral,0.014995
"Thin Film Drugs Market Size Expected to Reach USD 16.27 Billion in 2028, at a CAGR of 10.5%.",20230309T123018,https://www.benzinga.com/pressreleases/23/03/g31274383/thin-film-drugs-market-size-expected-to-reach-usd-16-27-billion-in-2028-at-a-cagr-of-10-5,PFE,0.078354,Neutral,0.023486
"The Daily Biotech Pulse: Pfizer/BioNTech's COVID-19 Booster For Kids, Moderna Starts First African Trial Of mRNA HIV Vaccine, Tonix Extends COVID-19 Antiviral Research Pact",20220518T141510,https://www.benzinga.com/general/biotech/22/05/27274688/the-daily-biotech-pulse-pfizerbiontechs-covid-19-booster-for-kids-5-11-years-moderna-starts-first,PFE,0.177193,Neutral,0.023019
"Earnings Scheduled For May 3, 2022",20220503T085235,https://www.benzinga.com/news/earnings/22/05/26953640/earnings-scheduled-for-may-3-2022,PFE,0.01558,Neutral,-0.004798
"Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant Growth by 2032, Evaluates DelveInsight | Key Players - Eli Lilly and Company, Phanes Therapeutics, Camurus AB, Advanced Accelerator Applications, PharmaMar",20240111T220100,https://www.prnewswire.com/news-releases/gastroenteropancreatic-neuroendocrine-tumors-market-to-showcase-a-significant-growth-by-2032-evaluates-delveinsight--key-players---eli-lilly-and-company-phanes-therapeutics-camurus-ab-advanced-accelerator-applications-pharma-302032286.html,PFE,0.075318,Neutral,0.02929
Colorectal Cancer Treatment Drug Market to Show Immense Growth During the Study Period  ( 2019-2032 )  | DelveInsight,20231121T220100,https://www.prnewswire.com/news-releases/colorectal-cancer-treatment-drug-market-to-show-immense-growth-during-the-study-period-20192032--delveinsight-301994315.html,PFE,0.092213,Neutral,-0.055925
"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer Bio",20230719T210100,https://www.prnewswire.com/news-releases/hypertension-market-to-accelerate-positively-estimates-delveinsight--key-companies-active-in-the-market---novartis-bayer-merck-insmed-acceleron-abbvie-alnylam--apnimed-astrazeneca-gossamer-bio-301880558.html,PFE,0.024801,Neutral,0.042885
"Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors",20230327T120000,https://www.prnewswire.com/news-releases/aadi-bioscience-appoints-mohammad-hirmand-md-to-board-of-directors-301781997.html,PFE,0.043579,Neutral,0.0
"5 Value Stocks To Watch In The Healthcare Sector - Innoviva  ( NASDAQ:INVA ) , Vicarious Surgical  ( NYSE:RBOT ) , Walgreens Boots Alliance  ( NASDAQ:WBA ) , Aadi Bioscience  ( NASDAQ:AADI ) , Pfizer  ( NYSE:PFE ) ",20221212T144338,https://www.benzinga.com/news/22/12/30042279/5-value-stocks-to-watch-in-the-healthcare-sector,PFE,0.166169,Neutral,0.070216
"Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period  ( 2019-2032 ) , Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo",20231004T210100,https://www.prnewswire.com/news-releases/small-cell-lung-cancer-market-to-accelerate-substantially-during-the-study-period-20192032-assesses-delveinsight--leading-companies----amgen-novartis-abbvie-bms-clovis-oncology-cardiff-oncology-roche-daiichi-sankyo-301946615.html,PFE,0.021778,Neutral,-0.092267
Dow Jumps 200 Points; Pfizer Earnings Top Views - Pfizer  ( NYSE:PFE ) ,20240730T141254,https://www.benzinga.com/news/earnings/24/07/40039782/dow-jumps-200-points-pfizer-earnings-top-views,PFE,0.287537,Neutral,0.045088
"Nasdaq Down Over 50 Points; Colgate-Palmolive Posts Upbeat Results - Colgate-Palmolive  ( NYSE:CL ) , AppFolio  ( NASDAQ:APPF ) ",20240126T193218,https://www.benzinga.com/news/earnings/24/01/36807767/nasdaq-down-over-50-points-colgate-palmolive-posts-upbeat-results,PFE,0.065327,Neutral,0.0
"Crude Oil Down 1%; American Express Shares Rise After Q4 Results - American Express  ( NYSE:AXP ) , AppFolio  ( NASDAQ:APPF ) ",20240126T170026,https://www.benzinga.com/news/earnings/24/01/36805309/crude-oil-down-1-american-express-shares-rise-after-q4-results,PFE,0.067347,Neutral,0.0
"Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Aldeyra Therapeutics  ( NASDAQ:ALDX ) , Alignment Healthcare  ( NASDAQ:ALHC ) ",20231016T170953,https://www.benzinga.com/news/23/10/35272489/why-streamline-health-solutions-shares-are-trading-lower-by-over-68-here-are-other-stocks-moving-in,PFE,0.076236,Somewhat-Bearish,-0.175071
Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket,20231016T131535,https://markets.businessinsider.com/news/stocks/why-contrafect-shares-are-trading-higher-by-around-30-here-are-20-stocks-moving-premarket-1032708380,PFE,0.105604,Somewhat-Bearish,-0.240048
"Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket - Ambrx Biopharma  ( NASDAQ:AMAM ) , Amphenol  ( NYSE:APH ) ",20231016T124712,https://www.benzinga.com/news/23/10/35266067/why-contrafect-shares-are-trading-higher-by-around-30-here-are-20-stocks-moving-premarket,PFE,0.097854,Somewhat-Bearish,-0.225147
"Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim",20230803T210100,https://www.prnewswire.com/news-releases/pancreatic-endocrine-tumor-market-is-expected-to-expand-at-a-healthy-growth-rate-by-2032-assesses-delveinsight--key-companies---merck-theradex-synergene-mirati-novartis-syntrix-biosystems-eli-lilly-boehringer-ingelheim-301892397.html,PFE,0.041466,Neutral,0.0
Processa Pharmaceuticals Appoints Khoso Baluch and James Neal to its Board of Directors and Justin Yorke to Chairman of the Board,20220816T123000,https://www.globenewswire.com/news-release/2022/08/16/2499067/0/en/Processa-Pharmaceuticals-Appoints-Khoso-Baluch-and-James-Neal-to-its-Board-of-Directors-and-Justin-Yorke-to-Chairman-of-the-Board.html,PFE,0.046816,Neutral,0.026632
"Schrödinger To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday - Green Dot  ( NYSE:GDOT ) , Foghorn Therapeutics  ( NASDAQ:FHTX ) ",20230629T125303,https://www.benzinga.com/news/23/06/33058152/schr-dinger-to-rally-around-14-here-are-10-other-analyst-forecasts-for-thursday,PFE,0.274834,Somewhat-Bullish,0.259031
"Stocks making the biggest moves midday: GameStop, Tesla, FedEx and more",20220318T163340,https://www.cnbc.com/2022/03/18/stocks-making-the-biggest-moves-midday-gamestop-tesla-and-more.html,PFE,0.086807,Neutral,0.001449
This overlooked corner of women's health could be a $350 billion market opportunity,20240315T183339,https://www.cnbc.com/2024/03/15/this-overlooked-corner-of-womens-health-could-be-a-350-billion-market-opportunity.html,PFE,0.0378,Neutral,0.098238
"Neuropathy Pain Treatment Market size to grow by USD 5.84 billion from 2023 to 2028, North America accounts for 33 ... - PR Newswire",20231214T221500,https://www.prnewswire.com/news-releases/neuropathy-pain-treatment-market-size-to-grow-by-usd-5-84-billion-from-2023-to-2028--north-america-accounts-for-33-of-market-growth--technavio-302015282.html,PFE,0.078099,Neutral,0.0
Black Diamond Therapeutics Announces Promotion of Melanie Morrison to Chief Development Officer - Black Diamond Therapeutic  ( NASDAQ:BDTX ) ,20230613T120000,https://www.benzinga.com/pressreleases/23/06/g32832558/black-diamond-therapeutics-announces-promotion-of-melanie-morrison-to-chief-development-officer,PFE,0.058615,Neutral,0.021003
"Ad giant Omnicom lifts the lid on its new generative AI platform ArtBotAI, which it says improves ad performance by 40%",20240710T130000,https://www.businessinsider.com/omnicom-launches-artbotai-generative-ai-ad-creation-platform-2024-7,PFE,0.039483,Neutral,0.0
"Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account ... - PR Newswire",20230918T091500,https://www.prnewswire.com/news-releases/breast-cancer-monoclonal-antibodies-market-to-grow-by-usd-15-billion-from-2022-to-2027-north-america-to-account-for-42-of-market-growth---technavio-301929309.html,PFE,0.043108,Neutral,0.0
Bispecific Antibody Clinical Trial Pipeline Appears Robust With 250+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight,20230703T210100,https://www.prnewswire.com/news-releases/bispecific-antibody-clinical-trial-pipeline-appears-robust-with-250-key-pharma-companies-actively-working-in-the-therapeutics-segment--delveinsight-301868673.html,PFE,0.020404,Neutral,-0.005463
"Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval - Incyte  ( NASDAQ:INCY ) ",20230323T113919,https://www.benzinga.com/general/biotech/23/03/31471634/incyte-would-now-compete-with-merck-pfizer-as-its-skin-cancer-treatment-scores-fda-accelerated-ap,PFE,0.271274,Bullish,0.383112
"Illumina, Seagen And Other Big Stocks Moving Higher On Monday - Agenus  ( NASDAQ:AGEN ) , First Majestic Silver  ( NYSE:AG ) ",20230313T145550,https://www.benzinga.com/news/23/03/31322709/illumina-seagen-and-other-big-stocks-moving-higher-on-monday,PFE,0.08183,Neutral,0.106086
"Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday - Amprius Technologies  ( NYSE:AMPX ) , ALFI  ( NASDAQ:ALF ) ",20221024T093702,https://www.benzinga.com/news/22/10/29374553/why-huntington-bancshares-shares-surged-around-10-here-are-72-biggest-movers-from-friday,PFE,0.031405,Somewhat-Bullish,0.186052
"After a covid-fuelled adrenaline rush, biotech is crashing",20220810T165426,https://www.economist.com/business/2022/08/10/after-a-covid-fuelled-adrenaline-rush-biotech-is-crashing,PFE,0.136113,Neutral,0.021005
The Stock Market Is Historically Pricey: Here's How I'm Positioning My Portfolio for 2025,20241221T100600,https://www.fool.com/investing/2024/12/21/stock-market-historically-pricey-portfolio-2025/,PFE,0.088581,Neutral,0.0
Pfizer  ( PFE )  Q3 2024 Earnings Call Transcript,20241029T213018,https://www.fool.com/earnings/call-transcripts/2024/10/29/pfizer-pfe-q3-2024-earnings-call-transcript/,PFE,0.067329,Neutral,0.138614
Biotech Plummets On 'Watershed Moment' For Its Field,20240702T125300,https://www.investors.com/news/technology/biotech-stock-cartesian-therapeutics-car-t-generalized-myasthenia-gravis/,PFE,0.165031,Bullish,0.45849
Market Cap Game Show: Andy Cross vs. Bill Mann,20240330T114500,https://www.fool.com/investing/2024/03/30/market-cap-game-show-andy-cross-vs-bill-mann/,PFE,0.007099,Neutral,0.027648
Thermo Fisher Scientific  ( TMO )  Q2 2023 Earnings Call Transcript,20230726T180022,https://www.fool.com/earnings/call-transcripts/2023/07/26/thermo-fisher-scientific-tmo-q2-2023-earnings-call/,PFE,0.00933,Neutral,0.118713
"As legal challenges mount, some companies retool diversity and inclusion programs",20240114T130139,https://apnews.com/article/dei-diversity-corporations-affirmative-action-309864f08e6ec63a45d18ca5f25d7540,PFE,0.070242,Neutral,0.005136
"Regional banks pace decliners, as biotech deals lift Seagen and Provention Bio",20230313T143200,https://www.marketwatch.com/story/regional-banks-pace-decliners-as-biotech-deals-lift-seagen-and-provention-bio-78a5d161,PFE,0.485711,Somewhat-Bullish,0.178968
"Nasdaq Drops Over 100 Points; Genius Sports Shares Spike Higher - ASLAN Pharma  ( NASDAQ:ASLN ) , Caribou Biosciences  ( NASDAQ:CRBU ) ",20230706T183021,https://www.benzinga.com/news/earnings/23/07/33138035/nasdaq-drops-over-100-points-genius-sports-shares-spike-higher,PFE,0.061473,Neutral,0.109017
"Dow Tumbles Over 300 Points; US Jobless Claims Increase More Than Projected - ASLAN Pharma  ( NASDAQ:ASLN ) , Allarity Therapeutics  ( NASDAQ:ALLR ) ",20230706T135215,https://www.benzinga.com/news/earnings/23/07/33133314/dow-tumbles-over-300-points-us-jobless-claims-increase-more-than-projected,PFE,0.06515,Neutral,0.109145
"Spectral AI Announces Voting Results from 2024 Annual Meeting of Stockholders and the Appointment of Erich Spangenberg to the Board of Directors - Spectral AI  ( NASDAQ:MDAIW ) , Spectral AI  ( NASDAQ:MDAI ) ",20240515T220521,https://www.benzinga.com/pressreleases/24/05/g38860891/spectral-ai-announces-voting-results-from-2024-annual-meeting-of-stockholders-and-the-appointment-,PFE,0.048621,Neutral,-0.011936
Spectral AI Announces Voting Results from 2024 Annual Meeting of Stockholders and the Appointment of Erich Spangenberg to the Board of Directors,20240515T220500,https://www.globenewswire.com/news-release/2024/05/15/2883007/0/en/Spectral-AI-Announces-Voting-Results-from-2024-Annual-Meeting-of-Stockholders-and-the-Appointment-of-Erich-Spangenberg-to-the-Board-of-Directors.html,PFE,0.054359,Neutral,0.01699
"MiMedx Group  ( NASDAQ:MDXG )  Lowered to ""Buy"" at StockNews.com",20230708T074249,https://www.defenseworld.net/2023/07/08/mimedx-group-nasdaqmdxg-lowered-to-buy-at-stocknews-com.html,PFE,0.068698,Neutral,0.066852
FreightCar America  ( NASDAQ:RAIL )  Coverage Initiated by Analysts at StockNews.com,20230709T051244,https://www.defenseworld.net/2023/07/09/freightcar-america-nasdaqrail-coverage-initiated-by-analysts-at-stocknews-com.html,PFE,0.051551,Neutral,0.076905
FreightCar America  ( NASDAQ:RAIL )  Now Covered by StockNews.com,20230225T065648,https://www.defenseworld.net/2023/02/25/freightcar-america-nasdaqrail-now-covered-by-stocknews-com.html,PFE,0.084722,Neutral,0.09082
FreightCar America  ( NASDAQ:RAIL )  Now Covered by StockNews.com,20230225T065646,https://reporter.am/2023/02/25/freightcar-america-nasdaqrail-now-covered-by-stocknews-com.html,PFE,0.084722,Neutral,0.09082
77 Stocks Moving In Tuesday's Mid-Day Session,20220510T160029,https://www.benzinga.com/news/22/05/27114947/77-stocks-moving-in-tuesdays-mid-day-session,PFE,0.059437,Neutral,0.001759
TETRA Technologies  ( NYSE:TTI )  Coverage Initiated by Analysts at StockNews.com,20221012T075441,https://reporter.am/2022/10/12/tetra-technologies-nysetti-coverage-initiated-by-analysts-at-stocknews-com.html,PFE,0.064276,Neutral,0.148193
Mid-Afternoon Market Update: Kymera Therapeutics Drops After Q1 Results; Belite Bio Shares Spike Higher,20220503T185426,https://www.benzinga.com/news/earnings/22/05/26973932/mid-afternoon-market-update-kymera-therapeutics-drops-after-q1-results-belite-bio-shares-spike-high,PFE,0.26822,Neutral,0.046555
Mid-Morning Market Update: Markets Mixed; Dow Drops 50 Points,20220503T143018,https://www.benzinga.com/news/earnings/22/05/26964110/mid-morning-market-update-markets-mixed-dow-drops-50-points,PFE,0.264515,Neutral,0.046555
Roche to Acquire CAR-T Cell Therapy Focused Poseida for $1.5B,20241126T155900,https://www.zacks.com/stock/news/2375474/roche-to-acquire-car-t-cell-therapy-focused-poseida-for-15b,PFE,0.09989,Neutral,0.062547
"Gene therapy market size to grow by USD 4.61 billion from 2022 to 2027, North America is estimated to contribute 39 ... - PR Newswire",20240318T093600,https://www.prnewswire.com/news-releases/gene-therapy-market-size-to-grow-by-usd-4-61-billion-from-2022-to-2027--north-america-is-estimated-to-contribute-39-to-the-growth-technavio-302090363.html,PFE,0.033562,Neutral,0.110176
"CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Cartesian, Arcellx, Novartis, Bristol-Myers Squibb, CARsgen, Poseida, Juno, CRISPR, bluebird bio",20230925T210100,https://www.prnewswire.com/news-releases/car-t-cell-therapy-for-multiple-myeloma-market-to-observe-stunning-growth-by-2032-evaluates-delveinsight--key-companies---cartesian-arcellx-novartis-bristol-myers-squibb-carsgen-poseida-juno-crispr-bluebird-bio-301937157.html,PFE,0.037504,Neutral,0.028556
"Acrivon Therapeutics Announces the Appointment of Seasoned Biopharma Executive Charles Baum, M.D., Ph.D., a Recognized Leader in Clinical Precision Oncology, to its Board of Directors - Acrivon Therapeutics  ( NASDAQ:ACRV ) ",20230622T200000,https://www.benzinga.com/pressreleases/23/06/g32975171/acrivon-therapeutics-announces-the-appointment-of-seasoned-biopharma-executive-charles-baum-m-d-ph,PFE,0.149038,Neutral,0.065536
"Torrid Reports Upbeat Results, Joins MBIA, Virco Mfg. And Other Big Stocks Moving Higher On Friday - Applied Optoelectronics  ( NASDAQ:AAOI ) , ALX Oncology Holdings  ( NASDAQ:ALXO ) ",20231208T154052,https://www.benzinga.com/news/23/12/36154924/torrid-reports-upbeat-results-joins-mbia-virco-mfg-and-other-big-stocks-moving-higher-on-friday,PFE,0.087503,Neutral,0.105169
"Job Cuts Today, What Tomorrow? Big Tech Faces Some Big Tests.",20230124T113100,https://www.barrons.com/amp/articles/what-to-know-today-51674547396,PFE,0.064507,Neutral,0.069557
VAALCO Energy  ( NYSE:EGY )  Now Covered by Analysts at StockNews.com,20221012T235603,https://www.etfdailynews.com/2022/10/12/vaalco-energy-nyseegy-now-covered-by-analysts-at-stocknews-com/,PFE,0.123526,Neutral,0.081877
Nasdaq Rises 2.5%; ACADIA Pharmaceuticals Shares Plummet,20220621T184259,https://www.benzinga.com/news/earnings/22/06/27800993/nasdaq-rises-2-5-acadia-pharmaceuticals-shares-plummet,PFE,0.070746,Neutral,0.020249
"Oil Stocks, Chemicals Expecting 57%-156% Growth In 2022",20220311T174200,https://www.investors.com/research/growth-stocks-to-buy-and-watch-in-2022/,PFE,0.195577,Neutral,0.009043
Pfizer  ( PFE )  Q1 Earnings and Revenues Beat Estimates,20240501T115505,https://www.zacks.com/stock/news/2265664/pfizer-pfe-q1-earnings-and-revenues-beat-estimates,PFE,0.404563,Neutral,0.146695
"Why WISeKey International Is Trading Higher By Over 20%; Here Are 29 Stocks Moving Premarket - American Rebel Holdings  ( NASDAQ:AREB ) , Biohaven  ( NYSE:BHVN ) ",20221006T101706,https://www.benzinga.com/news/22/10/29164422/why-wisekey-international-is-trading-higher-by-over-20-here-are-29-stocks-moving-premarket,PFE,0.057352,Neutral,0.0
"The Week Ahead In Biotech  ( June 5-11 ) : Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More",20220605T200922,https://www.benzinga.com/general/biotech/22/06/27558552/the-week-ahead-in-biotech-june-5-11-adcom-test-for-novavax-asco-presentations-enzo-biochem-earnin,PFE,0.121866,Neutral,0.080129
"Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday - Pfizer  ( NYSE:PFE ) ",20241007T140844,https://www.benzinga.com/news/24/10/41208395/pfizer-vista-outdoor-duckhorn-portfolio-and-other-big-stocks-moving-higher-on-monday,PFE,0.270773,Bullish,0.546029
Replimune Stock Rallies on BLA Filing for Melanoma Combo Drug,20241122T162300,https://www.zacks.com/stock/news/2374136/replimune-stock-rallies-on-bla-filing-for-melanoma-combo-drug,PFE,0.136888,Neutral,0.099096
Anaveon appoints Dieter Weinand as Chair of its Board of Directors,20240730T060000,https://www.benzinga.com/pressreleases/24/07/g40028529/anaveon-appoints-dieter-weinand-as-chair-of-its-board-of-directors,PFE,0.090134,Neutral,0.038482
"Head and Neck Squamous Cell Carcinoma Market to Witness Upsurge in Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Pfizer, Merck, Eisai, AstraZeneca, Innate, Roche, GlaxoSmithKline, BeiGene, IO Biotech, Incyte",20230918T210100,https://www.prnewswire.com/news-releases/head-and-neck-squamous-cell-carcinoma-market-to-witness-upsurge-in-growth-by-2032-assesses-delveinsight--key-companies-in-the-market---pfizer-merck-eisai-astrazeneca-innate-roche-glaxosmithkline-beigene-io-biotech-incyt-301930322.html,PFE,0.023146,Neutral,0.04357
Umoja Biopharma Appoints Dieter Weinand as the Chair of its Board of Directors,20221214T123000,https://www.benzinga.com/pressreleases/22/12/g30073538/umoja-biopharma-appoints-dieter-weinand-as-the-chair-of-its-board-of-directors,PFE,0.055751,Neutral,0.047895
"The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict",20220330T114641,https://www.benzinga.com/general/biotech/22/03/26367702/the-daily-biotech-pulse-roches-lung-cancer-combo-therapy-flunks-late-stage-study-adagio-spikes-on,PFE,0.087744,Neutral,0.024836
"The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation",20220517T130455,https://www.benzinga.com/general/biotech/22/05/27249090/the-daily-biotech-pulse-pfizer-biontechs-covid-19-booster-for-5-11-year-kids-soon-ultragenyx-in-l,PFE,0.08978,Neutral,-0.08853
"Moderna, Amazon, Tesla, And Other Big Gainers From Friday - Atara Biotherapeutics  ( NASDAQ:ATRA ) , Amazon.com  ( NASDAQ:AMZN ) ",20221024T081911,https://www.benzinga.com/news/22/10/29372471/moderna-amazon-tesla-and-other-big-gainers-from-friday,PFE,0.090474,Somewhat-Bullish,0.203148
"Moderna, BioNTech And Some Other Big Stocks Moving Higher On Wednesday - AZZ  ( NYSE:AZZ ) , BioNTech  ( NASDAQ:BNTX ) ",20221012T142846,https://www.benzinga.com/news/22/10/29237483/moderna-biontech-and-some-other-big-stocks-moving-higher-on-wednesday,PFE,0.252987,Neutral,0.005889
"Sangamo Therapeutics, Dave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Dave  ( NASDAQ:DAVE ) , ARKO  ( NASDAQ:ARKO ) ",20241231T134722,https://www.benzinga.com/24/12/42740288/sangamo-therapeutics-dave-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session,PFE,0.174587,Neutral,0.139374
"Why Cemtrex Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Alset  ( NASDAQ:AEI ) , Ambow Education Holding  ( AMEX:AMBO ) ",20241231T103326,https://www.benzinga.com/24/12/42737792/why-cemtrex-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-premarket,PFE,0.083833,Neutral,0.097711
Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated - Biogen  ( NASDAQ:BIIB ) ,20230728T155617,https://www.benzinga.com/analyst-ratings/analyst-color/23/07/33444357/reatas-acquisition-fits-biogens-strategy-despite-high-cost-analyst-says-high-level-,PFE,0.280615,Neutral,0.0
"Proactive news headlines including Haleon, GSK, Pfizer, Québec Nickel, Thunderbird Entertainment Group, GoviEx Uranium, Belmont Resources, Canada Silver Cobalt and Tocvan Ventures",20220920T175413,https://www.benzinga.com/pressreleases/22/09/g28937162/proactive-news-headlines-including-haleon-gsk-pfizer-qu-bec-nickel-thunderbird-entertainment-group,PFE,0.050359,Neutral,-0.021082
Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028 | DelveInsight,20230821T210100,https://www.prnewswire.com/news-releases/medical-second-opinion-global-market-to-register-stunning-growth-at-a-cagr-of-17-by-2028--delveinsight-301905294.html,PFE,0.048671,Neutral,-0.012897
"Dementia Market to Grow Rapidly, Estimates DelveInsight | Key Companies Active in the Market - Pfizer, Eli Lilly and Company, Janssen, Merck, BioVie, Biogen, Vivoryon, Sage, Alnylam, BioXcel, EIP, Otsuka, Alector, Transposon",20230726T210100,https://www.prnewswire.com/news-releases/dementia-market-to-grow-rapidly-estimates-delveinsight--key-companies-active-in-the-market---pfizer-eli-lilly-and-company-janssen-merck-biovie-biogen-vivoryon-sage-alnylam-bioxcel-eip-otsuka-alector-transposon-301885979.html,PFE,0.047607,Neutral,0.083205
This Week's 5-Stock Rate Cut Watchlist,20240916T115617,https://moneymorning.com/2024/09/16/this-weeks-5-stock-rate-cut-watchlist/,PFE,0.199859,Neutral,-0.011575
"Nasdaq, S&P Futures Rise As Microsoft, AMD Earnings Take Spotlight: Will Fed Provide 'Turbo Boost' For Market? Analyst Weighs In - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",20240730T112749,https://www.benzinga.com/news/earnings/24/07/40033855/nasdaq-s-p-futures-rise-as-microsoft-amd-earnings-take-spotlight-will-fed-provide-turbo-boost-for-m,PFE,0.079524,Neutral,0.0
"Tesla, Alphabet, SoFi, Paramount, Apple, Domino's, and More Stock Market Movers",20240429T082800,https://www.barrons.com/amp/articles/stock-market-movers-4c54f840,PFE,0.06515,Neutral,-0.057048
"Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",20240429T055121,https://www.benzinga.com/news/earnings/24/04/38481553/will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports,PFE,0.069294,Neutral,0.0
"Stocks Handle Huge Earnings, Fed, Jobs Report: Weekly Review",20240202T171500,https://www.investors.com/news/stock-market-handles-huge-earnings-week-fed-powell-jobs-report-weekly-review/,PFE,0.049835,Neutral,-0.136008
"SoFi, iRobot, Tesla, Archer Daniels, McGrath RentCorp, ZoomInfo, and More Stock Market Movers",20240129T092400,https://www.barrons.com/amp/articles/stock-market-movers-149f2d69,PFE,0.06211,Neutral,0.0
"Apple earnings, Fed decision and jobs data top Wall Street week ahead",20231029T163803,https://www.foxbusiness.com/markets/apple-earnings-fed-decision-and-jobs-data-top-wall-street-week-ahead,PFE,0.07031,Neutral,0.080345
"Stocks making the biggest moves premarket: Uber, Gap, Caterpillar & more",20230801T121106,https://www.cnbc.com/2023/08/01/stocks-making-the-biggest-moves-premarket-uber-gap-cat.html,PFE,0.124164,Somewhat-Bearish,-0.204185
Week Heavy on Labor Data Commences,20230731T143600,https://www.zacks.com/stock/news/2129936/week-heavy-on-labor-data-commences,PFE,0.148273,Neutral,0.061553
"SOFI, ON Beat in Q2, Ahead of Jobs Week",20230731T140700,https://www.zacks.com/stock/news/2129911/sofi-on-beat-in-q2-ahead-of-jobs-week,PFE,0.143843,Neutral,0.06048
Akari Therapeutics Announces Key Leadership Appointments - Akari Therapeutics  ( NASDAQ:AKTX ) ,20241218T135129,https://www.benzinga.com/pressreleases/24/12/g42553004/akari-therapeutics-announces-key-leadership-appointments,PFE,0.023579,Neutral,0.116935
Akari Therapeutics Announces Key Leadership Appointments,20241218T135100,https://www.globenewswire.com/news-release/2024/12/18/2999072/0/en/Akari-Therapeutics-Announces-Key-Leadership-Appointments.html,PFE,0.024496,Neutral,0.119418
Top Penny Stocks To Buy? 3 To Watch Before Next Week,20230706T194208,https://pennystocks.com/featured/2023/07/06/top-penny-stocks-to-buy-3-to-watch-before-next-week/,PFE,0.122269,Somewhat-Bullish,0.199399
Incannex Healthcare Quarterly Activities Report and Appendix 4C Cash Flow Statement - Incannex Healthcare  ( NASDAQ:IXHL ) ,20221028T120000,https://www.benzinga.com/pressreleases/22/10/g29456485/incannex-healthcare-quarterly-activities-report-and-appendix-4c-cash-flow-statement,PFE,0.063383,Neutral,0.087286
Incannex Healthcare Quarterly Activities Report and Appendix 4C Cash Flow Statement,20221028T120000,https://www.globenewswire.com/news-release/2022/10/28/2543791/0/en/Incannex-Healthcare-Quarterly-Activities-Report-and-Appendix-4C-Cash-Flow-Statement.html,PFE,0.064405,Neutral,0.08837
Unrivaled Brands & Other Cannabis Operators Just Made Some Key Executive Changes You Should Know About,20220819T162130,https://www.benzinga.com/markets/cannabis/22/08/28568471/delic-holdings-other-cannabis-operators-just-made-some-key-executive-changes-you-should-know-abo,PFE,0.095517,Neutral,0.05658
"Icannex Taps Ex Pfizer, FDA & Regulatory Affairs Expert",20220817T150059,https://www.benzinga.com/markets/cannabis/22/08/28536850/icannex-taps-ex-pfizer-fda-regulatory-affairs-expert,PFE,0.272029,Somewhat-Bullish,0.183049
Incannex Appoints FDA Regulatory Affairs Expert Mr Robert B. Clark to the Board of Directors,20220817T120000,https://www.globenewswire.com/news-release/2022/08/17/2499923/0/en/Incannex-Appoints-FDA-Regulatory-Affairs-Expert-Mr-Robert-B-Clark-to-the-Board-of-Directors.html,PFE,0.233556,Neutral,0.119824
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday,20220808T070540,https://www.benzinga.com/news/22/08/28391297/why-quoin-pharmaceuticals-plunged-over-62-here-are-120-biggest-movers-from-friday,PFE,0.016668,Neutral,0.0
96 Biggest Movers From Yesterday,20220315T085138,https://www.benzinga.com/news/22/03/26136650/96-biggest-movers-from-yesterday,PFE,0.023216,Neutral,0.015732
96 Biggest Movers From Yesterday,20220315T085138,https://markets.businessinsider.com/news/stocks/96-biggest-movers-from-yesterday-1031280260,PFE,0.023638,Neutral,0.017928
"5 Value Stocks In The Healthcare Sector - Agile Therapeutics  ( NASDAQ:AGRX ) , Sensus Healthcare  ( NASDAQ:SRTS ) , Revelation Biosciences  ( NASDAQ:REVB ) , First Wave BioPharma  ( NASDAQ:FWBI ) , Pfizer  ( NYSE:PFE ) ",20230612T144411,https://www.benzinga.com/news/23/06/32817507/5-value-stocks-in-the-healthcare-sector,PFE,0.207571,Somewhat-Bullish,0.239399
PFE: These 3 Stocks Are a Must When Building Your Dividend Portfolio,20221028T194501,https://stocknews.com/news/pfe-icl-arc-these-3-stocks-are-a-must-when-building-your-dividend/,PFE,0.325924,Somewhat-Bullish,0.206765
PFE: 3 Dividend Stocks to Buy That'll Pay You Forever,20221018T194108,https://stocknews.com/news/pfe-icl-karo-3-dividend-stocks-to-buy-thatll-pay-you-forever/,PFE,0.366061,Somewhat-Bullish,0.197142
Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates - Pfizer  ( NYSE:PFE ) ,20240501T183212,https://www.benzinga.com/news/earnings/24/05/38561882/dow-jumps-200-points-following-fed-decision-pfizer-earnings-top-estimates,PFE,0.2035,Neutral,-0.066229
"Pfizer  ( PFE ) , Arvinas Post Upbeat Data From Breast Cancer Study",20231206T161800,https://www.zacks.com/stock/news/2194285/pfizer-pfe-arvinas-post-upbeat-data-from-breast-cancer-study,PFE,0.318897,Neutral,0.002365
"Triple-Negative Breast Cancer Market to Accelerate Substantially During the Forecast Period  ( 2023-2032 ) , Examines DelveInsight | Key Companies to Watch - Roche, AbbVie, AstraZeneca, BeiGene, GlaxoSmithKline, Genentech, Eli Lilly, Novartis",20230906T210100,https://www.prnewswire.com/news-releases/triple-negative-breast-cancer-market-to-accelerate-substantially-during-the-forecast-period-20232032-examines-delveinsight--key-companies-to-watch---roche-abbvie-astrazeneca-beigene-glaxosmithkline-genentech-eli-lilly--301918858.html,PFE,0.022494,Neutral,-0.053504
"The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill",20220707T140337,https://www.benzinga.com/general/biotech/22/07/27983728/the-daily-biotech-pulse-mercks-potential-seagen-buyout-expected-in-weeks-fda-holds-diamedicas-str,PFE,0.130358,Neutral,0.014352
"The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand Disease | Key Analysis by DelveInsight",20231009T210100,https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-factor-based-bleeding-disorders-hemophilia-a-hemophilia-b-and-von-willebrand-disease--key-analysis-by-delveinsight-301950491.html,PFE,0.036338,Neutral,0.034129
RIGL: 1 Pharma Stock to Buy for Under $1 This December,20221212T130959,https://stocknews.com/news/rigl-nvo-pfe-bmy-1-pharma-stock-to-buy-for-under-1-this-december/,PFE,0.136499,Neutral,0.097382
LAVA Reports Third Quarter 2024 Financial Results and Announces Pipeline Reprioritization and Cash Runway Extension into 2027,20241210T123000,https://www.globenewswire.com/news-release/2024/12/10/2994415/0/en/LAVA-Reports-Third-Quarter-2024-Financial-Results-and-Announces-Pipeline-Reprioritization-and-Cash-Runway-Extension-into-2027.html,PFE,0.072362,Neutral,0.074831
LAVA Reports Second Quarter 2024 Financial Results and Business Update,20240820T113000,https://www.globenewswire.com/news-release/2024/08/20/2932711/0/en/LAVA-Reports-Second-Quarter-2024-Financial-Results-and-Business-Update.html,PFE,0.100203,Neutral,0.060158
LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference,20240620T113000,https://www.globenewswire.com/news-release/2024/06/20/2901588/0/en/LAVA-Therapeutics-to-Participate-in-the-H-C-Wainwright-2nd-Annual-Immune-Cell-Engager-Virtual-Conference.html,PFE,0.122894,Neutral,0.05596
LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference - LAVA Therapeutics  ( NASDAQ:LVTX ) ,20240620T113000,https://www.benzinga.com/pressreleases/24/06/g39408416/lava-therapeutics-to-participate-in-the-h-c-wainwright-2nd-annual-immune-cell-engager-virtual-conf,PFE,0.100729,Neutral,0.047422
LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results,20240521T110000,https://www.globenewswire.com/news-release/2024/05/21/2885427/0/en/LAVA-Provides-Business-Updates-and-Reports-First-Quarter-2024-Financial-Results.html,PFE,0.141227,Neutral,0.051276
LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052  ( formerly SGN-EGFRd2/LAVA-1223 ) ,20240305T123000,https://www.globenewswire.com/news-release/2024/03/05/2840325/0/en/LAVA-Announces-Clinical-Development-Milestone-Achieved-by-Pfizer-for-PF-08046052-formerly-SGN-EGFRd2-LAVA-1223.html,PFE,0.166398,Neutral,0.083598
"Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses DelveInsight | Key Companies in the Market - Beam, Pfizer, Genentech, AbbVie, Fate, Roche, Ascentage, Janssen, Jazz, ADC, Kymera, Syndax, ImmunoGen",20230913T210100,https://www.prnewswire.com/news-releases/acute-lymphocytic-leukemia-market-to-accelerate-substantially-by-2032-assesses-delveinsight--key-companies-in-the-market---beam-pfizer-genentech-abbvie-fate-roche-ascentage-janssen-jazz-adc-kymera-syndax-immunogen-301925772.html,PFE,0.021897,Neutral,0.047845
Hot Penny Stocks To Watch As The Stock Market Crash Continues,20220926T183016,https://pennystocks.com/featured/2022/09/26/hot-penny-stocks-to-watch-as-the-stock-market-crash-continues/,PFE,0.075995,Neutral,0.032291
Molecular Glues Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight,20240711T213100,https://www.prnewswire.com/news-releases/molecular-glues-clinical-trial-pipeline-appears-robust-with-10-key-pharma-companies-actively-working-in-the-therapeutics-segment--delveinsight-302194515.html,PFE,0.049784,Neutral,0.027682
Monte Rosa Therapeutics Announces Leadership Team Promotions - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ,20240530T110000,https://www.benzinga.com/pressreleases/24/05/g39081952/monte-rosa-therapeutics-announces-leadership-team-promotions,PFE,0.054983,Neutral,0.019
Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors - Monte Rosa Therapeutics  ( NASDAQ:GLUE ) ,20230323T113000,https://www.benzinga.com/pressreleases/23/03/g31471796/monte-rosa-therapeutics-appoints-dr-jan-skvarka-to-board-of-directors,PFE,0.072655,Neutral,0.07548
Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors,20230323T113000,https://www.globenewswire.com/news-release/2023/03/23/2633019/0/en/Monte-Rosa-Therapeutics-Appoints-Dr-Jan-Skvarka-to-Board-of-Directors.html,PFE,0.04794,Neutral,0.074087
Immix Biopharma 12 Month Review Progress Update,20240221T143100,https://www.globenewswire.com/news-release/2024/02/21/2832855/0/en/Immix-Biopharma-12-Month-Review-Progress-Update.html,PFE,0.020404,Neutral,-0.026128
"Immix Biopharma Subsidiary Nexcella Appoints Edward J. Borkowski, former Chief Financial Officer of Mylan N.V, to Board of Directors",20230622T135300,https://www.globenewswire.com/news-release/2023/06/22/2693043/0/en/Immix-Biopharma-Subsidiary-Nexcella-Appoints-Edward-J-Borkowski-former-Chief-Financial-Officer-of-Mylan-N-V-to-Board-of-Directors.html,PFE,0.035293,Neutral,0.048254
"Immix Biopharma Subsidiary Nexcella Appoints Henry McKinnell, Jr., former Chairman & CEO of Pfizer Inc., to Board of Directors",20230612T134900,https://www.globenewswire.com/news-release/2023/06/12/2686410/0/en/Immix-Biopharma-Subsidiary-Nexcella-Appoints-Henry-McKinnell-Jr-former-Chairman-CEO-of-Pfizer-Inc-to-Board-of-Directors.html,PFE,0.14028,Neutral,0.025497
SecureWorks  ( NASDAQ:SCWX )  Upgraded by StockNews.com to Hold,20230708T081644,https://www.defenseworld.net/2023/07/08/secureworks-nasdaqscwx-upgraded-by-stocknews-com-to-hold.html,PFE,0.069495,Neutral,0.138299
Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC,20241107T133000,https://www.globenewswire.com/news-release/2024/11/07/2976690/34858/en/Vaccinex-Provides-Update-on-ActivMAb-Platform-Multiple-Project-Deals-and-Presentation-at-SITC.html,PFE,0.038655,Neutral,0.058602
Cadence Design and Ligand have been highlighted as Zacks Bull and Bear of the Day,20230721T130400,https://www.zacks.com/stock/news/2125288/cadence-design-and-ligand-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,PFE,0.016227,Somewhat-Bullish,0.198649
Bear of the Day: Ligand Pharmaceuticals  ( LGND ) ,20230721T102000,https://www.zacks.com/commentary/2124960/bear-of-the-day-ligand-pharmaceuticals-lgnd,PFE,0.118064,Somewhat-Bullish,0.251012
5 Biotech Stocks to Buy as Industry Prospects for 2H23 Look Good,20230613T133000,https://www.zacks.com/commentary/2107444/5-biotech-stocks-to-buy-as-industry-prospects-for-2h23-look-good,PFE,0.023191,Neutral,0.069874
Here's How Much a $1000 Investment in Ligand Pharmaceuticals Made 10 Years Ago Would Be Worth Today,20230419T123004,https://www.zacks.com/stock/news/2080898/heres-how-much-a-1000-investment-in-ligand-pharmaceuticals-made-10-years-ago-would-be-worth-today,PFE,0.059636,Neutral,0.064017
"Zacks Industry Outlook Highlights CRISPR Therapeutics, Ligand Pharmaceuticals, Theseus Pharmaceuticals and Kala Pharmaceuticals",20230322T113700,https://www.zacks.com/stock/news/2068930/zacks-industry-outlook-highlights-crispr-therapeutics-ligand-pharmaceuticals-theseus-pharmaceuticals-and-kala-pharmaceuticals,PFE,0.026013,Neutral,0.017488
4 Biotech Stocks to Consider for Your Portfolio in 2023,20230321T153200,https://www.zacks.com/commentary/2068484/4-biotech-stocks-to-consider-for-your-portfolio-in-2023,PFE,0.02689,Neutral,0.098044
